Bright Minds Biosciences Inc. DRUG
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -73.86%
- 1 year
- -64.48%
Held by funds
29 US ETFs and mutual funds hold DRUG · largest positions
- IWM 0.01% of fund $3.82M
- VTWO 0.01% of fund $2.29M
- IWO 0.01% of fund $1.39M
- PSIL 2.63% of fund $998.09K
- IWC 0.04% of fund $444.72K
- VTWG 0.03% of fund $424.17K
- GWX 0.02% of fund $193.74K
- IWMW* MX 0.01% of fund $123.22K
- SMMD 0.00% of fund $84.31K
- RSSL 0.01% of fund $77.42K
- IWV 0.00% of fund $42.91K
- VTHR 0.00% of fund $32.27K
- IBRN 0.26% of fund $21.18K
- ITWO 0.00% of fund $8.24K
- URTY 0.00% of fund $5.75K
- UWM 0.00% of fund $3.77K
- IWMW 0.01% of fund $2.73K
- HDG 0.00% of fund $186
- ITDF 0.00% of fund $150
- ITDE 0.00% of fund $131
Ownership
- Institutions 44.3%
- Insiders 27.3%
- Public and other holders 28.4%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Investments, LLC | 2.63% | 182,420 | 7.06M | Sep 29, 2024 |
| National Bank of Canada/FI | 0.07% | 4,959 | 191.86K | Sep 29, 2024 |
| UBS Group AG | 0.05% | 3,407 | 131.82K | Sep 29, 2024 |
| Royal Bank of Canada | 0.01% | 660 | 25.54K | Sep 29, 2024 |
| Aspire Private Capital, LLC | 0.00% | 100 | 3.87K | Sep 29, 2024 |
| Blackrock Inc. | 0.00% | 1 | 38 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 0.00% | 297 | 11.49K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs DRUG, and what each was last paid
Ian McDonald, Co-Founder, Chief Executive Officer, President & DirectorAverage age 53
| Name | Title | Pay | Age |
|---|---|---|---|
| Ian McDonald | Co-Founder, Chief Executive Officer, President & Director | — | 38 |
| Jan Torleif Pedersen | Chief Science Officer & Director | 520K CAD | 61 |
| Ryan E. S. K. Cheung | CFO & Corporate Secretary | 95.5K CAD | 48 |
| Emer Leahy | Consultant | — | 59 |
| Stephen D. Collins | Chief Medical Officer | — | 73 |
| Alex Vasilkevich | Chief Operating Officer & Senior Scientific Officer | — | 37 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Fryzuk (Jeremy) | Director of Issuer | Acquisition or disposition in the public market | Aug 23, 2022 | 30,000 |
| Kozikowski Alan P | 10% Security Holder of Issuer | Acquisition or disposition in the public market | Dec 29, 2021 | 2,002,500 |
| McDonald (Ian) | Director of Issuer | Acquisition or disposition in the public market | Dec 14, 2021 | 914,900 |
